The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Liu David Y since 2017.
This trader's CIK number is 1675881.
At the time of last reporting, Liu David Y was the Chief R&D Strategy Officer of Protagonist Therapeutics, Inc. (stock ticker symbol PTGX).
Also see all insider trading activities at Protagonist Therapeutics, Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | PTGX | 0 | $0 | 0 | $0 | 301,437 | $604,077 |
| 2021 | PTGX | 0 | $0 | 14,779 | $702,889 | 10,000 | $8,700 |
| 2019 | PTGX | 0 | $0 | 8,026 | $66,112 | 0 | $0 |
| 2018 | PTGX | 0 | $0 | 5,250 | $109,501 | 5,250 | $18,041 |
| 2017 | PTGX | 0 | $0 | 15,750 | $250,642 | 14,875 | $44,353 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-11-16 | PTGX | Option Ex | 100,479 | 2.00 | 201,359 |
| 2022-11-16 | PTGX | Option Ex | 100,479 | 2.00 | 201,359 |
| 2022-11-16 | PTGX | Option Ex | 100,479 | 2.00 | 201,359 |
| 2021-08-17 | PTGX | Option Ex | 10,000 | .87 | 8,700 |
| 2021-08-17 | PTGX | Sale | 14,779 | 47.56 | 702,889 |
| 2019-08-06 | PTGX | Sale | 3,395 | 8.85 | 30,045 |
| 2019-03-01 | PTGX | Sale | 810 | 8.03 | 6,504 |
| 2019-02-06 | PTGX | Sale | 3,821 | 7.74 | 29,563 |
| 2018-03-12 | PTGX | Option Ex | 3,500 | 4.21 | 14,735 |
| 2018-03-12 | PTGX | Sale | 3,500 | 21.29 | 74,501 |
| 2018-03-02 | PTGX | Option Ex | 875 | 1.89 | 1,653 |
| 2018-03-02 | PTGX | Sale | 875 | 20.00 | 17,500 |
| 2018-01-16 | PTGX | Sale | 875 | 20.00 | 17,500 |
| 2018-01-16 | PTGX | Option Ex | 875 | 1.89 | 1,653 |
| 2017-12-18 | PTGX | Option Ex | 875 | 1.89 | 1,653 |
| 2017-12-18 | PTGX | Sale | 875 | 20.00 | 17,500 |
| 2017-11-30 | PTGX | Sale | 875 | 20.00 | 17,500 |
| 2017-11-13 | PTGX | Sale | 7,000 | 16.97 | 118,762 |
| 2017-11-13 | PTGX | Option Ex | 7,000 | 3.05 | 21,350 |
| 2017-08-28 | PTGX | Option Ex | 3,500 | 4.21 | 14,735 |
| 2017-08-28 | PTGX | Sale | 3,500 | 15.00 | 52,500 |
| 2017-07-10 | PTGX | Option Ex | 3,500 | 1.89 | 6,615 |
| 2017-07-10 | PTGX | Sale | 3,500 | 12.68 | 44,380 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Liu David Y (Chief R&D Strategy Officer of Protagonist Therapeutics, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.